Contact lens maker Bausch + Lomb says it is exploring sale
Adds share performance in paragraph 4, background in paragraph 6-9
Dec 12 (Reuters) -Bausch + Lomb BLCO.TO is exploringa potential sale among otheroptions, it said on Thursday, in a move that would help Canadianparent Bausch Health BHC.TO exit the eye-care company.
Bausch + Lomb also said its statement was in response to a request from the Canadian Investment Regulatory Organization (CIRO) after a series of media reports on its likely sale triggered volatility in its shares.
The Financial Times reported on Oct. 14 that private equity firms TPG and Blackstone were working on a joint bid to take the company private for up to $11.5 billion, including debt.
A month prior, the FT had reported that the company had hired an investment bank to explore a sale, sending its shares surging more than 37% until the newspaper's report on Blackstone's cooling interest earlier this week led to a sharp fall in its stock price.
A sale could end a long process by parent Bausch Health to offload its stake in the eyecare company.
In 2022, Bausch Health separated the business into another publicly listed company but retained a majority stake.
Bausch + Lomb, which is one of the world's largest contact lens suppliers, is helmed by noted dealmaker Brent Saunders.
He was previously the CEO of Allergan before it was sold to AbbVie ABBV.N for $63 billion.
The company also makes surgical devices, prescription drugs and generic eye products.
Reporting by Puyaan Singh, Kashish Tandon, Sriparna Roy and Mariam Sunny in Bengaluru; Editing by Alan Barona and Anil D'Silva
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
